TickerFactsScreenerDevelopers

InMed Pharmaceuticals Inc. (INM) — Revenue

Annual figures by fiscal year, from SEC filings.

2022: $1.09M2023: $4.14M2024: $4.60M2025: $4.94M$4.94M
2022Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$4.94M+7.5%
2024$4.60M+11.2%
2023$4.14M+279.6%
2022$1.09M—